Pharmaceutical Development and Bioavailability Analysis

Dear colleagues,

The frontiers of pharmaceutical development have been broadly extended over the past few years, with a significant impact on the research, design, and manufacture of both novel synthetized substances and classic molecules that need an updating of their formulation or their bioavailability and use. In the century of nanoscale, the scientific and clinical approaches of pharmaceuticals are challenging and, in many cases, the necessity of emphasizing practical solutions and applications to theoretical and research-based problems occurs.

Nowadays, pharmaceutical development faces a large host of issues deriving from the particularities of each pharmacological active principle, from botanicals to biologics and biosimilars. In many cases, these molecules or the already formulated drugs create controversies regarding the bioavailability, interactions, novel potential mechanisms of action with consequences on their efficacy and risks.

Therefore, in this Special Issue titled “Pharmaceutical Development and Bioavailability Analysis”, we encourage researchers to present the most recent studies regarding various developments in the pharmaceutical field, with a strong focus on the drugs’ bioavailability and potential effects on the formulation, delivery systems, pharmacokinetics, interactions, and preclinical and clinical significance. The manuscripts may include research articles and reviews in order to advance the pharmaceutical development.

Prof. Dr. Andreea Letitia Arsene
Dr. Denisa Udeanu
Dr. Bruno Velescu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Processes is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.